Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Merck KGaA
Pharma
Merck-Curon, Legend, Amgen—Fierce Pharma Asia
Merck licensed a bispecific from Curon. Legend is taking a close look at its business. The FDA flagged missing adverse events in an Amgen filing.
Angus Liu
Aug 16, 2024 8:59am
Merck KGaA, analysts share optimism about potential CDMO rebound
Aug 7, 2024 3:13pm
MilliporeSigma plugs €62M into new quality control building
Jun 14, 2024 10:00am
Novo, Novartis, BMS among pharmas celebrating LGBTQ+ Pride month
Jun 12, 2024 11:40am
Lotte Biologics, Merck KGaA partner for biopharma production
Jun 3, 2024 1:38pm
AstraZeneca, Hengrui, Takeda—Fierce Pharma Asia
May 24, 2024 8:31am
